U.S. drugmaker Merck & Co. joined Gilead Sciences Inc. on April 27 in lending support to India as the world’s second-most populous country scrambles to address drug shortages and bring a raging new wave of Covid-19 cases under control.
The number of Covid-19 deaths in the United States crossed 250,000, according to a Reuters tally, as a third coronavirus wave brings a fresh surge in infections and puts immense strain on the healthcare system.
Unilever is to buy GlaxoSmithKline’s Horlicks nutrition business for $3.8 billion, boosting the Anglo-Dutch group’s position in India by adding the popular malted drink.
Americans pay the highest prices in the world for cancer drugs, but the treatments are least affordable in lower income countries.
India’s Supreme Court has refused to hear two lawsuits filed by one of the country’s best-known whistleblowers which accused drugs and health regulators of failing to enforce safety standards, the whistleblower and his lawyer said on Friday. Dinesh Thakur, who exposed dangerous practices in India’s drugs industry in 2013, filed the public interest litigations in […]
On January 15, the Government of India launched a nationwide mobile health program designed to train community health workers and to directly reach millions of women within three years. The program is powered by MOTECH, a mobile health technology developed by Grameen Foundation, with support from the Bill & Melinda Gates Foundation. “Until now, mHealth […]
Leaders of India’s $15 billion pharmaceuticals industry, a major supplier of affordable generics to the world, have joined public health activists in criticizing a new U.S.-led trade deal they say will delay the arrival of new cheap drugs. The impact of the Trans-Pacific Partnership (TPP) struck last week between 12 nations, which include the United […]
India, which has dominated the generic drugs industry for decades, is falling behind in the race to make copies of complex biotech drugs, which are expected to generate tens of billions of dollars in sales in the coming years. While Indian firms have launched a few such products on the domestic market, where regulatory […]
The U.S. Food and Drug Administration (FDA) and the World Health Organisation have intensified investigations into India’s clinical research firms, industry officials said, after recent probes revealed two leading firms had violated standards. The scrutiny is likely to further hurt India’s reputation as a global pharmaceutical hub, as it follows sanctions imposed by the FDA […]